SHINE Technologies Names Harrie Buurlage Chief Commercial Officer of Isotopes

Veteran global leader in nuclear medicine will oversee business and go to market strategies for therapeutic and diagnostic isotopes JANESVILLE, Wis., Sept. 11, 2023 /PRNewswire/ — SHINE Technologies, LLC, a next-generation fusion technology company, today announced that Harrie Buurlage…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.